Why Is Nanomix (OTCMKTS:NNMX) Stock Up 20% In a Month?

Those who may be looking into stocks that managed to clock strong gains over the course of the past week may do well to take at the Nanomix (OTCMKTS:NNMX) stock. The company came into significant focus among investors over the course of the past week and managed to clock gains of as much as 20% during the period.

Trading Data

On Tuesday, NNMX stock ended flat at $0.75 with more than 422 shares, compared to a volume of 582 shares. The stock moved within a range of $0.7500 – 0.7500 after opening trade at $0.75.

About Nanomix

The company is best known for its work related to the development of its NanōmixeLab® System platform which is meant for providing a mobile point of care diagnostics services. The products that Nanomix has come up with are meant for improving healthcare delivery by bringing the vital aspect of diagnostics as the initial point of interaction with the patient.

However, in this context, it is also important to point out that the company is also working on a range of other tests in its pipeline that have the sole purpose of bringing about improvement in patient outcomes.

Nanomix Receives IVDR Certification for the eLab Analyzer

Yesterday, the company was actually in the news after it announced that it had been awarded the EU Quality Management System Certificate for its eLab analyser under the provisions of the In Vitro Diagnostic Medical Devices Regulation.

The product in question is a part of the company’s eLab System platform. The latest certification from the European Union is a significant development for the company since it provides a higher category of patent protection to companies.

David Ludvigson, who is the President and Chief Executive Officer of the company, spoke about the latest development too. He stated that the certification was a major new milestone for the company especially after having received the CE mark designation for the company’s platform from the European Union previously.

The European Union had decided to transition to the latest IVDR regulation from the IVDD regulation and it may be seen as an important milestone for the company since it is now completely compliant with the regulation of a major continent. It will be interesting to see if the latest developments bring further bullish trigger to the stock or not over the course of the coming days.

Key Quote

“Achieving IVDR certification is an important milestone for our eLab system, which follows the CE mark designation in Europe for our S1 assay panel using a whole blood sample type,” stated David Ludvigson, President and Chief Executive Officer of Nanomix.